DXR Daxor Corp
Daxor Corp (DXR) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
Where they traded
Last open-market purchase: April 8, 2026 , by Feldschuh Michael Richard .
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Feldschuh Michael Richard | Chief Executive Officer | Buy | 1,000 | $9.07 | $9.1K | 213,694 | |
| Michel Robert J | Chief Financial Officer | Buy | 1,000 | $9.90 | $9.9K | 21,050 | |
| Jefferies John 2 fills | Chief Medical Officer | Buy | 5,941 | $0.00 | $0 | 23,557 | |
| Michel Robert J | Chief Financial Officer | Buy | 3,000 | $0.00 | $0 | 20,050 | |
| Feldschuh Jonathan Adam | Chief Scientific Officer | Buy | 18,000 | $0.00 | $0 | 53,908 | |
| Jefferies John | Chief Medical Officer | Buy | 2,344 | $0.00 | $0 | 17,616 |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.